Myriad Genetics, Inc. (MYGN) Receives the Charles R. Smart Visionary Award From the American Cancer Society  
6/7/2012 9:50:26 AM

SALT LAKE CITY, June 6, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics announced today that the Company is the honorable recipient of the 2012 Charles R. Smart Visionary Award from the American Cancer Society's Salt Lake City office, a part of the Great West Division. This award is presented annually at the Society's Legacy & Leadership event to recognize organizations that have made extraordinary efforts in the fight against cancer.